This is the first agreement the EIB has signed with a corporate venture capital in healthcare sector, and states that Angelini Ventures and the EIB will each invest €75 million over the next six years. Under the agreement, the EIB and Angelini plan to co-invest in a total of seven to ten European startups developing innovative solutions particularly suited for market launch, in areas such as biotechnology, medical technology and digital health.

The Hogan Lovells team that advised on the transaction was led by partner Alessandro Accrocca and included associates Edoardo Minnetti and Noemi Biagini, and trainee Riccardo Del Torto.